Absci is a generative AI drug creation company dedicated to accelerating the development of biologics for patient care. By leveraging advanced artificial intelligence and state-of-the-art wet lab capabilities, Absci is transforming how new antibodies and therapeutics are designed and developed from the ground up. With headquarters in the Pacific Northwest and an AI research lab in New York City, the company seeks to redefine the drug discovery process through innovative approaches and collaborative teamwork. Absci values grit, creativity, and a commitment to pushing the boundaries of science, striving to deliver breakthrough therapeutics at unprecedented speed. As part of its mission, Absci fosters a multidisciplinary culture where original thinkers and passionate scientists work together to achieve meaningful advancements in healthcare.